本文内容已经过同行评议,以优先出版方式在线发表,可作为有效引用数据。由于优先发表的内容尚未完成规范的编校流程,《中华外科杂志》不保证其数据与印刷版内容的完全一致。 【引用本文】陈凌,刘凤林.食管胃结合部腺癌的定义和分型:从历史到现状[J/OL].中华外科杂志,2022,60:网络预发表. 陈凌 刘凤林 {复旦大学附属中山医院普通外科} 通信作者:刘凤林,Email:liu.fenglin@zs-hospital.sh.cn 近年来,食管胃结合部腺癌(adenocarcinoma of esophagogastric junction,AEG)的发病率明显上升,引起学界的日益重视[1, 2]。但食管胃结合部(esophagogastric junction,EGJ)横跨胸腔和腹腔两大解剖区域,又具有不同于食管和胃的组织学特征,即便是定义、分型等基本问题,不同学科的认识并不一致,东西方学者的观点也多有分歧,从而导致治疗策略、手术方式、预后判断等关键问题难以统一观点[3]。除腺癌外,EGJ还会发生鳞状细胞癌,其临床特点和处理原则又与AEG不同。我们拟从历史的维度,对EGJ及AEG定义和分型的变迁,以及存在的争议和分歧加以梳理,以期为相关研究提供借鉴。 一、EGJ的定义 二、EGJ的功能和解剖 三、AEG的定义与分型 四、主要指南和规范对AGE定义和分型的规定 五、启示与展望 参考文献 (在框内滑动手指即可浏览) [1]ManabeN, MatsuedaK, HarumaK. Epidemiological review of gastroesophageal junction adenocarcinoma in Asian countries[J]. Digestion, 2022, 103(1):29-36. DOI: 10.1159/000519602. [2]TanPO, SohA, KusanoC, et al. Is There an increasing incidence of gastroesophageal junctional adenocarcinoma and Barrett esophagus in Asia? A review of diagnostic conundrums[J]. Digestion, 2022, 103(1):37-44. DOI: 10.1159/000519922. [3]袁勇, 陈心足, 胡建昆, 等. 食管胃结合部腺癌外科治疗中国专家共识(2018年版)解读[J].中华胃肠外科杂志, 2019, 22(2):101-106. DOI:10.3760/cma.j.issn.1671-0274.2019.02.001. [4]HuangQ. Definition of the esophagogastric junction: a critical mini review[J]. Arch Pathol Lab Med, 2011, 135(3):384-389. DOI: 10.5858/2010-0162-RA.1. [5]MittalRK, BalabanDH. The esophagogastric junction[J]. N Engl J Med, 1997, 336(13):924-932. DOI: 10.1056/NEJM199703273361306. [6]TakuboK, AidaJ, SawabeM, et al. The normal anatomy around the oesophagogastric junction: a histopathologic view and its correlation with endoscopy[J]. Best Pract Res Clin Gastroenterol, 2008, 22(4):569-583. DOI: 10.1016/j.bpg.2008.02.004. [7]SharmaP, McQuaidK, DentJ, et al. A critical review of the diagnosis and management of Barrett′s esophagus: the AGA Chicago Workshop[J]. Gastroenterology, 2004, 127(1):310-330. DOI: 10.1053/j.gastro.2004.04.010. [8]EctorsN, DriessenA, De HertogG, et al. Is adenocarcinoma of the esophagogastric junction or cardia different from Barrett adenocarcinoma?[J]. Arch Pathol Lab Med, 2005, 129(2):183-185. DOI: 10.5858/2005-129-183-IAOTEJ. [9]SrivastavaA, OdzeRD, LauwersGY, et al. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia[J]. Am J Surg Pathol, 2007, 31(11):1733-1741. DOI: 10.1097/PAS.0b013e318078ce91. [10]韩方海, 杨斌. 解读第15版日本胃癌处理规约[J].中华胃肠外科杂志, 2018, 21(4):409-412. DOI: 10.3760/cma.j.issn.1671-0274.2018.04.010. [11]GhoshSK. Biomechanics of the esophagogastric junction in gastroesophageal reflux disease[J]. Curr Gastroenterol Rep, 2008, 10(3):246-251. DOI:10.1007/s11894-008-0051-6. [12]VogtCD, Panoskaltsis-MortariA. Tissue engineering of the gastroesophageal junction[J]. J Tissue Eng Regen Med, 2020, 14(6):855-868. DOI: 10.1002/term.3045. [13]ViannaA, HayesPC, MoscosoG, et al. Normal venous circulation of the gastroesophageal junction. A route to understanding varices[J]. Gastroenterology, 1987, 93(4):876-889. DOI: 10.1016/0016-5085(87)90453-7. [14]陶凯, 任一鹏, 李林杰, 等. 回归基础解剖探索食管胃结合部肿瘤外科治疗的困惑与争议[J].中华外科杂志, 2021, 59(5):324-327.DOI:10.3760/cma.j.cn112139-20210204-00066. [15]WangY, ZhuL, XiaW, et al. Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer[J]. Cancer Manag Res, 2018, 10:6295-6303. DOI: 10.2147/CMAR.S182436. [16]赵骏杰, 刘凤林. 食管胃结合部腺癌腹腔镜近端胃切除术及淋巴结清扫[J].中华胃肠外科杂志, 2022, 25(2):114-119. DOI:10.3760/cma.j.cn441530-20211103-00446. [17]SaitoH, FukumotoY, OsakiT, et al. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach[J]. World J Surg, 2006, 30(10):1864-1869. DOI: 10.1007/s00268-005-0582-z. [18]KurokawaY, TakeuchiH, DokiY, et al. Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study[J]. Ann Surg, 2021, 274(1):120-127. DOI:10.1097/SLA.0000000000003499. [19]中华医学会外科学分会腹腔镜与内镜外科学组. Siewert Ⅱ型食管胃结合部腺癌腔镜手术治疗中国专家共识(2019版)[J].中国实用外科杂志, 2019, 39(11):1129-1135. DOI:10.19538/j.cjps.issn1005-2208.2019.11.02. [20]KumamotoT, KurahashiY, NiwaH, et al. True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends[J]. Surg Today, 2020, 50(8):809-814. DOI:10.1007/s00595-019-01843-4. [21]Rüdiger SiewertJ, FeithM, WernerM, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1, 002 consecutive patients[J]. Ann Surg, 2000,232(3):353-361.DOI:10.1097/00000658-200009000-00007. [22]SiewertJR, SteinHJ. Classification of adenocarcinoma of the oesophagogastric junction[J]. Br J Surg, 1998, 85(11):1457-1459. DOI: 10.1046/j.1365-2168.1998.00940.x. [23]FeithM, SteinHJ, SiewertJR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients[J]. Surg Oncol Clin N Am, 2006, 15(4):751-764. DOI: 10.1016/j.soc.2006.07.015. [24]SiewertJR, FeithM. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer[J]. J Am Coll Surg, 2007, 205(4Suppl):S49-S53. DOI: 10.1016/j.jamcollsurg.2007.06.324. [25]李增山, 李青. 2010年版消化系统肿瘤WHO分类解读[J].中华病理学杂志, 2011, 40(5):351-354. DOI: 10.3760/cma.j.issn.0529-5807.2011.05.019. [26]RiceTW, BlackstoneEH, RuschVW. 7th editionof the AJCC Cancer Staging Manual: esophagus and esophagogastric junction[J]. Ann Surg Oncol, 2010, 17(7):1721-1724. DOI: 10.1245/s10434-010-1024-1. [27]SuhYS, HanDS, KongSH, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification[J]. Ann Surg, 2012, 255(5):908-915. DOI: 10.1097/SLA.0b013e31824beb95. [28]StrongVE, D′AmicoTA, et al. Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers[J]. J Natl Compr Canc Netw, 2013, 11(1):60-66. DOI: 10.6004/jnccn.2013.0009. [29]ZhaoE, LingT, XuJ, et al. Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution[J]. Int J Clin Exp Med, 2015, 8(7):10668-10677. [30]言成一, 陈龙奇. 回眸2019——聚焦食管胃结合部肿瘤的外科治疗[J].中华胃肠外科杂志, 2020, 23(1):20-25. DOI: 10.3760/cma.j.issn.1671-0274.2020.01.004. [31]DaikoH, KatoK. Updates in the 8th edition of the TNM staging system for esophagus and esophagogastric junction cancer[J]. Jpn J Clin Oncol, 2020, 50(8):847-851. DOI: 10.1093/jjco/hyaa082. [32]RiceTW, PatilDT, BlackstoneEH. 8th editionAJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice[J]. Ann Cardiothorac Surg, 2017, 6(2):119-130. DOI: 10.21037/acs.2017.03.14. [33]GonzalezRS, RazaA, PropstR, et al. Recent advances in digestive tract tumors: updates from the 5th edition of the World Health Organization “Blue Book”[J]. Arch Pathol Lab Med, 2021, 145(5):607-626. DOI: 10.5858/arpa.2020-0047-RA. [34]HuangQ, ReadM, GoldJS, et al. Unraveling the identity of gastric cardiac cancer[J]. J Dig Dis, 2020, 21(12):674-686. DOI: 10.1111/1751-2980.12945. [35]RiceTW, GressDM, PatilDT, et al. Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual[J]. CA Cancer J Clin, 2017, 67(4):304-317. DOI: 10.3322/caac.21399. [36]BookaE, TakeuchiH, KitagawaY. Esophageal cancer practice guidelines in Japan[M]//Ando N. Esophageal squamous cell carcinoma: diagnosis and treatment. Singapore: Springer Singapore, 2020:131-147. [37]Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition)[J]. Gastric Cancer, 2021,24(1):1-21.DOI:10.1007/s10120-020-01042-y. [38]国际食管疾病学会中国分会(CSDE)食管胃结合部疾病跨界联盟, 中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会外科医师分会上消化道外科医师专业委员会, 等. 食管胃结合部腺癌外科治疗中国专家共识(2018年版)[J].中华胃肠外科杂志, 2018, 21(9):961-975. DOI: 10.3760/cma.j.issn.1671-0274.2018.09.001. |
|
来自: zhaozhaozhao3 > 《胃外科》